How accurate are fourth-generation combination tests for HIV
WEBFourth-generation tests detect both HIV antibodies and p24 antigen, which are present in the blood shortly after infection. They have high sensitivity and specificity, but the window period is estimated at 18 days, with 99% of infections being detected within 44 days.
How likely is mother-to-child transmission of HIV? - Aidsmap
WEBThe web page explains how HIV can be transmitted from a pregnant woman to her baby during pregnancy, labour, delivery and breastfeeding. It also describes how effective HIV treatment and other measures can reduce the transmission risk to very low levels, and provides some statistics and references.
What are the side-effects of post-exposure prophylaxis (PEP)?
WEBLearn about the possible side-effects of post-exposure prophylaxis (PEP), a method of preventing HIV infection after exposure. Compare the recommended combination of emtricitabine/tenofovir and raltegravir with other options, …
CD4 cell counts - Aidsmap
WEBLearn about CD4 cell counts, a measure of immune system health for people living with HIV. Find out how CD4 counts are used to guide HIV treatment decisions, monitor disease progression and prevent infections.
Female-to-female sexual transmission of HIV - Aidsmap
WEBThe risk of female-to-female sexual transmission is extremely rare, with only six reported cases. These cases involved sharing of sex toys and exposure to blood during sex, and the women had other risk factors such as injecting drug use or sex with men.
Odefsey - Aidsmap
WEBOdefsey is a once-daily pill that contains three antiretroviral drugs: rilpivirine, emtricitabine and tenofovir alafenamide. It is used to treat HIV infection and reduce the risk of passing it on, but it has some side effects and interactions with other medicines.
Trans women 66 times more likely to have HIV, with trans men
WEBMar 14, 2022 · Trans women have a 66 times higher odds of HIV than the general population, while trans men have a 6.8 times higher odds, according to a meta-analysis of 98 studies from 34 countries. The study found regional differences, with sub-Saharan Africa and Latin America having the highest prevalence among trans women.
Biktarvy - Aidsmap
WEBBiktarvy is a once-daily pill that contains three antiretroviral drugs: bictegravir, emtricitabine and tenofovir alafenamide. It is used to treat HIV infection and reduce the risk of passing it on, but it has some side effects and interactions with other medicines.
CD4/CD8 ratio - Aidsmap
WEBThe CD4/CD8 ratio is a reflection of immune system health, with a normal ratio being between 1 and 3. HIV infection can change the ratio to less than 1, increasing the risk of lung and anal cancer.
Gammora does not cure HIV - Aidsmap
WEBGammora is a new drug that claims to reduce viral load by 90% in four weeks, but it is not a cure and has not been tested properly. The press release by Zion Medical is misleading and has been criticised by experts as bad science and quackery.